Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity

This study presents the background, rationale and method of action of Biovacc-19, a candidate vaccine for corona virus disease 2019 (Covid-19), now in advanced preclinical development, which has already passed the first acute toxicity testing. Unlike conventionally developed vaccines, Biovacc-19’s m...

Descripción completa

Detalles Bibliográficos
Autores principales: Sørensen, Birger, Susrud, Andres, Dalgleish, Angus George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468800/
https://www.ncbi.nlm.nih.gov/pubmed/34192262
http://dx.doi.org/10.1017/qrd.2020.8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468800/
https://www.ncbi.nlm.nih.gov/pubmed/34192262
http://dx.doi.org/10.1017/qrd.2020.8

Ejemplares similares